| Project Scope | |||
|---|---|---|---|
This project team will create a users guide or White Paper with recommendations | for analysis for analysis and displays for Laboratory Data, with a focus on Phase 2-4 clinical trials and integrated submission documents. There have been 2 previous White Papers on this topic (1 for central tendency in 2013 and 1 for | outliersOutliers/ | shifts Shifts in 2015). This paper will combine two method types and update recommendations given the advancement in interactive options. |
| Project Leads |
|---|
Wei Wang
| Charles Beasley, Beasley Pharmaceutical and Biotechnology Consulting | charlesmbeasleyjr@msn.com |
Charles Beasley
Wendy Dobson (PHUSE Project Manager)
| Christopher Smith, FDA | christopher.smith2@fda.hhs.gov |
| Nicola Newton, PHUSE Project Assistant |
|
|---|
Q3 2023 |
|---|
Project Closed. |
Objectives & Deliverables | Timelines |
|---|---|
Align on next steps | Q2 2023 |